For most of us, a cancer diagnosis would be the worst possible news. But a remarkable new documentary, Second Winds, captures ...

AbbVie has turned to award-winning, Oscar-nominated director Dominic Gill to help it highlight the lives of people living ...

Chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the Western Hemisphere, affecting approximately ...

AbbVie has released ‘Second Winds’, which captures the lived experience of three people diagnosed with chronic lymphocytic ...

The discussion will explore the impact of fixed-duration treatments on quality of life, benefits and challenges compared with continuous therapy, financial considerations, and lifestyle goals during ...

AbbVie (NYSE: ABBV) announced today the launch of Second Winds, a new short film that captures the powerful, deeply personal journeys of three people living with chronic lymphoma leukemia (CLL), a ...

“Second Winds” is a short documentary film that captures the powerful, deeply personal journeys of three individuals living ...

Researchers of a new study explore what areas of chronic lymphocytic leukemia (CLL) treatment and care are important to patients and identify key areas for improvement. The research, completed in ...

Chronic Lymphocytic Leukaemia (CLL) is the most common adult blood cancer in the western world, and it predominantly affects older adults. Most people are diagnosed after the age of 70, but increasing ...

Chester Freeman shares how the Japanese philosophy of wabi-sabi helped him embrace his scar and find beauty in imperfection while living with leukemia. Chester Freeman, living with chronic lymphocytic ...

About 50% of patients with CLL/SLL have high-risk molecular features limiting effectiveness of certain treatments; a blood test can identify these features and help guide which therapy is most likely ...

While some evidence suggests that people living with CLL may have a limited immune response, health experts still encourage those with blood cancers to follow guidelines for recommended COVID-19 ...